Pet Drug Reports

Drugs by active ingredient

Drug · single active ingredient

Ampicillin Trihydrate: adverse event reports

All products with this active ingredient · 12 FDA-approved applications in the Green Book

648reports naming this ingredient, 1989–20260.1% of all reports · about 18 a year
22reports, 12 months to March 202614 in the 12 months before
69.5%classed serious, as reportedof 259 reports stating it
21.6%record death or euthanasia, as reported140 reports
27.9%of reports concern dogs0% of all dog reports

Between July 1989 and February 2026 FDA received 648 adverse event reports listing a drug with ampicillin trihydrate as the recorded active ingredient. The Green Book lists 12 FDA-approved applications with this single active ingredient.

openFDA masks the brand and manufacturer in every report, so these figures describe the ingredient across all products and cannot be attributed to a brand.

In the 12 months to March 2026, 22 reports named it, up 57% from 14 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Over its whole reporting history that is about 18 reports a year and 0.1% of all 1,357,245 reports (0% of all dog reports). How many animals received it is not published, so a count says nothing about how often a problem occurs per dose.

The signs named most often are death (14%), solution, Abnormal (10%) and suspension, Abnormal (8.6%). A report can list several signs, so shares add to more than 100%; 540 different terms appear across these reports.

27.9% of reports concern dogs. Not every report describes illness: 33.2% as product or packaging defects. Of reports that state seriousness, 69.5% were classed as serious, and 21.6% of all reports record a death or euthanasia as an outcome, as reported. FDA has not necessarily determined whether any drug played a part.

Monthly reports by species, five years

Dog22 · peak 3
Apr 2021: 1Jun 2021: 1Oct 2021: 1Nov 2022: 1Mar 2023: 2Apr 2023: 1May 2023: 2Jun 2023: 1Feb 2024: 3Aug 2024: 2Feb 2025: 1Mar 2025: 1May 2025: 1Jul 2025: 1Aug 2025: 1Sep 2025: 1Nov 2025: 12022202320242025
Cat7 · peak 1
Jun 2021: 1Sep 2022: 1Feb 2024: 1Sep 2024: 1Apr 2025: 1Dec 2025: 1Feb 2026: 12022202320242025
Horse0 · peak 1
2022202320242025
Other72 · peak 5
Apr 2021: 2May 2021: 4Jun 2021: 1Jul 2021: 1Oct 2021: 2Dec 2021: 1Jan 2022: 2Feb 2022: 1Apr 2022: 2Jun 2022: 1Jul 2022: 1Sep 2022: 3Oct 2022: 1Nov 2022: 1Dec 2022: 4Jan 2023: 3Feb 2023: 1Apr 2023: 1May 2023: 3Aug 2023: 1Sep 2023: 5Oct 2023: 2Jan 2024: 1Feb 2024: 1Mar 2024: 4May 2024: 5Jul 2024: 1Oct 2024: 1Feb 2025: 1Mar 2025: 1Apr 2025: 2May 2025: 2Jun 2025: 1Jul 2025: 3Sep 2025: 1Oct 2025: 1Dec 2025: 2Feb 2026: 22022202320242025

Reports by the month FDA received them. Each panel has its own scale; the peak month is printed at the top right. The newest months are incomplete because FDA posts reports with a delay of three to six months.

Reports by year received

030591989: 419891990: 31991: 11992: 11993: 119931994: 71995: 71996: 41997: 619971998: 411999: 592000: 32001: 920012002: 122003: 112004: 182005: 1220052006: 172007: 152008: 182009: 1720092010: 232011: 212012: 232013: 3020132014: 472015: 242016: 502017: 1820172018: 222019: 82020: 122021: 1820212022: 182023: 222024: 202025: 2320252026: 3

2026 covers reports received through March 2026 only.

Signs listed in reports

share of ampicillin trihydrate reports listing the termall dog reports

  1. Death14%91
  2. Solution, Abnormal[a product quality report, not a sign in an animal]10%65
  3. Suspension, Abnormal[a product quality report, not a sign in an animal]8.6%56
  4. Death by euthanasia[the animal was euthanized]5.4%35
  5. Anaphylaxis[sudden severe allergic-type reaction]4.9%32
  6. Anorexia[not eating]4.6%30
  7. Injection site swelling[swelling where the injection was given]4.6%30
  8. Vomiting4.2%27
  9. Injection site pain[pain where the injection was given]3.9%25
  10. Dyspnoea[difficulty breathing]3.7%24
  11. Color, Abnormal[a product quality report, not a sign in an animal]3.1%20
  12. Lethargy[unusually tired or inactive]3.1%20
  13. Diarrhoea[diarrhea]2.9%19
  14. Fever2.9%19
  15. Anaemia NOS[low red blood cell count]2.8%18
  16. Hives2.6%17
  17. Leucocytosis NOS[high white blood cell count]2.6%17
  18. Other abnormal test result NOS[abnormal laboratory result, type not specified]2.6%17
  19. Elevated blood urea nitrogen (BUN)[a kidney value above the normal range]2.3%15
  20. Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]2.3%15
  21. Vials, Damaged[a product quality report, not a sign in an animal]2.3%15
  22. Overdose[more than the labelled amount was given]2%13
  23. Depression[dull, quiet or withdrawn]1.9%12
  24. Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]1.9%12
  25. Facial oedema[swollen face]1.9%12

Top 30 of 540 coded terms (VeDDRA, the veterinary reporting dictionary; plain-language gloss in brackets). One report can list several terms. The ticks show how often the same term appears in a wider pool of reports; they describe the reports, and FDA cautions that such figures cannot be used to estimate risk or to compare one product with another. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand.

Outcomes and report types

Outcome recorded in the report

Recovered/Normal15.9%103
Recovered with Sequela1.4%9
Ongoing2.2%14
Died16.5%107
Euthanized5.2%34
Outcome Unknown7.6%49

What kind of report it was

Safety issue63.4%411
Lack of expected effectiveness2.3%15
Both safety and lack of expected effectiveness0.9%6
Manufacturing or product defect33.2%215
Other0.2%1

Coloured bar: reports naming ampicillin trihydrate. Grey bar: all 1,357,245 reports in the database. Outcomes are the status at the time of the last report, as stated by the reporter; a report covering several animals can carry more than one outcome. FDA has not necessarily determined whether any drug played a part in any outcome.

Species and breeds in the reports

Species

Dog27.9%181
Cattle25.3%164
Cat11.3%73
Horse1.1%7
Other0.6%4
Human exposure0.3%2

Single-breed animals

Breed shares follow how common each breed is. Crossbred animals and reports with no breed stay in the species figure only.

Age, weight and route

Age of the animal

Under 1 year13.9%90
1 to 3 years12%78
4 to 7 years13.1%85
8 to 11 years5.2%34
12 years and over3.2%21
Age not given52.5%340

Weight of the animal

Under 5 kg (11 lb)12%78
5 to 9.9 kg (11–22 lb)8.3%54
10 to 24.9 kg (22–55 lb)6.2%40
25 to 44.9 kg (55–99 lb)4.6%30
45 kg and over (99 lb+)13.9%90
Weight not given54.9%356

Route of administration stated in reports: subcutaneous (152), intramuscular (124), intravenous (22), parenteral (5), oral (2), other (1).

In context

MeasureAmpicillin TrihydrateAll dog reportsAll reports
Reports648985,6751,357,245
Share of that pool's reports naming this drug—0%0.1%
Classed serious, of reports stating it69.5%38.3%38.6%
Death or euthanasia recorded, per 1,000 reports2165563.8
Filed as lack of expected effectiveness (wholly or partly)3.2%—23%
Top term, share of reportsDeath 14%2.9%—

This set accounts for 100% of all reports naming ampicillin trihydrate, so no separate ingredient column is shown. Shares are of reports, not of animals treated. The number of doses sold is not public, so none of these figures is a rate of occurrence, and differences between columns reflect which animals receive a drug and who reports as much as anything else.

FDA-approved products containing ampicillin trihydrate (Green Book)

Reference information, not report statistics. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The list below is the FDA Green Book as of 1 Oct 2026; nothing on this page says which of these products, if any, a report concerned.

Trade nameActive ingredientsSponsorApproved forApplication
PolyflexAmpicillin TrihydrateBoehringer Ingelheim Animal Health USA, Inc.Dogs, Cats, CattleNADA 055-030
Ampi-TabAmpicillin TrihydrateZoetis Inc.DogsNADA 055-042
Princillin InjectionAmpicillin TrihydrateZoetis Inc.Cattle, SwineNADA 055-064
Princillin InjectionAmpicillin TrihydrateZoetis Inc.Dogs, CatsNADA 055-066
Princillin Injection 200 mgAmpicillin TrihydrateZoetis Inc.SwineNADA 055-071
Ampi-BolAmpicillin TrihydrateZoetis Inc.CattleNADA 055-074
Ampi-JectAmpicillin TrihydrateZoetis Inc.DogsNADA 055-079
Ampicillin TrihydrateAmpicillin TrihydrateHQ Specialty Pharma Corp.Dogs, Cats, CattleANADA 200-180
Princillin Capsules 125 mg; Princillin Capsules 250 mg; Princillin Capsules 500 mgapproval voluntarily withdrawnAmpicillin TrihydrateNorbrook Laboratories, Ltd.Dogs, CatsNADA 055-036
Princillin Soluble Powderapproval voluntarily withdrawnAmpicillin TrihydrateNorbrook Laboratories, Ltd.SwineNADA 055-050
Princillin Bolusapproval voluntarily withdrawnAmpicillin TrihydrateNorbrook Laboratories, Ltd.CattleNADA 055-056
Princillin "125" For Oral Suspensionapproval voluntarily withdrawnAmpicillin TrihydrateNorbrook Laboratories, Ltd.Dogs, CatsNADA 055-061

Species are the major species the Green Book search lists for the application ("—" where it lists another species or none). Approval dates are not part of the Green Book listing files and are not shown. Pioneer applications (NADA) come first, then generics (ANADA).

Questions about ampicillin trihydrate reports

How many adverse event reports has FDA received for ampicillin trihydrate?

648 reports record a drug with ampicillin trihydrate as its active ingredient in the openFDA release of 28 Sep 2026, covering reports received through March 2026. 22 of them arrived in the latest 12 months.

Which brand do these reports concern?

That cannot be known from the public data. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The Green Book lists 12 approved applications with this ingredient alone; the reference list on this page names them without any counts.

What signs are reported most often?

death (14%), solution, Abnormal (10%), suspension, Abnormal (8.6%), death by euthanasia (5.4%) and anaphylaxis (4.9%). These are the coded terms listed in reports; several can appear in one report, and a term's presence is not a finding that the drug was responsible.

Which species and breeds appear in these reports?

dog (27.9%), cattle (25.3%) and cat (11.3%). Among single-breed animals the most frequent labels are Holstein-Friesian, Domestic, Labrador Retriever and Domestic Shorthair; popular breeds appear often in any drug's reports because there are more of them.

Are reports rising?

22 reports in the 12 months to March 2026, up 57% from 14 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Counts also move with sales, publicity and time on the market.

Do these reports show that ampicillin trihydrate harms pets?

Report counts cannot show that. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources." FDA also notes that commonly used products may have more reports simply because more animals receive them.

Are these the side effects of ampicillin trihydrate?

They are signs listed in reports, not an established list of side effects. The adverse reactions observed in studies are printed on each product's FDA-approved label, which a veterinarian can go through with you. This page is a record of what was reported to FDA.

How do I report a problem with an animal drug?

FDA asks owners and veterinarians to call the drug company first (the number is on the label); companies must pass reports to FDA. Reports can also go directly to FDA on Form FDA 1932a. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. Drug entries are grouped by the active ingredients their unmasked ingredient field discloses; the application number that records also carry is not used. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.